AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox


Neuphoria Therapeutics Inc. has intensified its strategic review process, appointing H.C. Wainwright & Co. as a financial advisor to explore options that could maximize stockholder value. The company's board emphasized the importance of stability and expertise, citing the recent appointment of Peter Davies and David Wilson, who bring decades of investment banking and healthcare sector experience. Davies, a former Managing Director at Rothschild, has advised on over $100 billion in transactions, while Wilson's background in capital markets adds depth to the board's capabilities. The board is currently evaluating multiple proposals from interested parties, with discussions
.Meanwhile, the legal sector continues to see high-profile developments. Byju's founder Byju Raveendran faces a $1 billion default judgment from a Delaware court, which ruled against him for non-compliance in the Alpha Funds case. The court also
, further complicating the company's financial landscape. Separately, over potential misrepresentations, urging investors to contact the firm to discuss legal options.
Ogunbufunmi's journey underscores the value of leveraging diverse experiences. "Do not ignore your home experiences," she advises, emphasizing the importance of self-belief and consistent visibility in career transitions. Her work spans sectors including FinTech and e-commerce, with notable roles at Amazon Web Services, Flutterwave, and the Nigerian Vice President's office. She encourages aspiring professionals to commit to their goals, ask themselves how badly they want success, and show up consistently to build their networks
.Quickly understand the history and background of various well-known coins

Dec.02 2025

Dec.02 2025

Dec.02 2025

Dec.02 2025

Dec.02 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet